GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Common Stock

Novartis AG (MEX:NVS N) Common Stock : MXN16,539 Mil (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Common Stock?

Novartis AG's quarterly common stock increased from Jun. 2024 (MXN14,528 Mil) to Sep. 2024 (MXN15,614 Mil) and increased from Sep. 2024 (MXN15,614 Mil) to Dec. 2024 (MXN16,539 Mil).

Novartis AG's annual common stock declined from Dec. 2022 (MXN17,351 Mil) to Dec. 2023 (MXN14,004 Mil) but then increased from Dec. 2023 (MXN14,004 Mil) to Dec. 2024 (MXN16,539 Mil).


Novartis AG Common Stock Historical Data

The historical data trend for Novartis AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Common Stock Chart

Novartis AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,161.40 18,483.11 17,351.44 14,003.76 16,538.57

Novartis AG Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,003.76 13,160.83 14,527.84 15,614.41 16,538.57

Novartis AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Novartis AG Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines